// App-Quantinova.ai

3941 : Novel biomarkers and multiplexed NGS to stratify FFPE NSCLC by tumor infiltrating lymphocytes and histopathology phenotypes

Researchers

Presenter

  • Ann Mongan

Principal Investigators

  • Sophie Rozenzhak

  • Geoffrey Bien

  • David Chi

  • Hiroyoshi Nishikawa

  • Fiona Hyland

  • Jim Godsey

Medical Centers

  • ThermoFisher, South San Francisco, CA

  • National Cancer Center, EPOC, Chiba, Japan

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Squamous cell carcinoma

  • Small cell lung cancer

  • Solid malignancies

  • Lung Cancer

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved